DONALD BERRY to Karyotyping
This is a "connection" page, showing publications DONALD BERRY has written about Karyotyping.
Connection Strength
0.021
-
Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia. J Clin Oncol. 2003 May 01; 21(9):1722-7.
Score: 0.012
-
Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol. 1998 Mar; 16(3):1008-12.
Score: 0.009